Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V O Frick

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Scandinavian Journal of Immunology|June 25, 2013
CCR6/CCL20 chemokine expression profile in distinct colorectal malignanciesV O Frick, C Rubie, K Kölsch, et al.
Scandinavian Journal of Immunology|October 31, 2008
Differential CXC receptor expression in colorectal carcinomasC Rubie, O Kollmar, V O Frick, et al.
The Journal of Cardiovascular Surgery|March 3, 2015
Proangiogenic potency of MUC18 in arteriosclerotic diseaseR Shayesteh-Kheslat, A Kauffels, C Rubie, et al.
Scandinavian Journal of Immunology|June 13, 2006
Enhanced expression and clinical significance of CC-chemokine MIP-3 alpha in hepatocellular carcinomaC Rubie, V O Frick, M Wagner, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Scandinavian Journal of Immunology|June 25, 2013
CCR6/CCL20 chemokine expression profile in distinct colorectal malignanciesV O Frick, C Rubie, K Kölsch, et al.
Scandinavian Journal of Immunology|October 31, 2008
Differential CXC receptor expression in colorectal carcinomasC Rubie, O Kollmar, V O Frick, et al.
The Journal of Cardiovascular Surgery|March 3, 2015
Proangiogenic potency of MUC18 in arteriosclerotic diseaseR Shayesteh-Kheslat, A Kauffels, C Rubie, et al.
Scandinavian Journal of Immunology|June 13, 2006
Enhanced expression and clinical significance of CC-chemokine MIP-3 alpha in hepatocellular carcinomaC Rubie, V O Frick, M Wagner, et al.
Pageof 1